| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/05/1995 | CA2143514A1 Antitumor compositions and methods of treatment |
| 09/05/1995 | CA2142154A1 Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors |
| 09/05/1995 | CA2142153A1 Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors |
| 09/05/1995 | CA2039874C 4'-demethylepipodophyllotoxin glycosides |
| 09/05/1995 | CA2010017C Composition for reparation and prevention of fibrotic lesions |
| 09/05/1995 | CA2006425C Transdermal therapeutical system comprising norpseudoephedrine as active component |
| 09/05/1995 | CA1336913C Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase |
| 09/05/1995 | CA1336912C Phosphoric acid diesters and salts thereof |
| 09/05/1995 | CA1336911C Serotonin antagonists |
| 09/05/1995 | CA1336909C Heterocyclic derivatives |
| 09/05/1995 | CA1336906C Lactam derivatives |
| 09/05/1995 | CA1336905C Pyrido [3,2,1,ij]-1,3,4-benzoxadiazine derivatives |
| 09/05/1995 | CA1336903C 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives |
| 09/05/1995 | CA1336891C Use of substituted 3,4-dihydro-2h-benzopyrans as remedies for obstructive functional disorders of the lungs and/or disorders of the efferent urinary passages |
| 09/05/1995 | CA1336890C Amphotericin b/cholesterol sulfate composition and method |
| 09/05/1995 | CA1336889C Treatment of iodine deficiency diseases |
| 09/05/1995 | CA1336887C Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
| 09/05/1995 | CA1336886C Phenethanolamine and growth hormone combinations |
| 09/04/1995 | CA2143691A1 Acetamides |
| 09/03/1995 | CA2143725A1 Process for the preparation of allyl quinone derivatives, and intermediates |
| 09/03/1995 | CA2143544A1 Pharmaceutical agents for the treatment of myocardial reperfusion injury and myocardial stunning |
| 09/03/1995 | CA2141999A1 Methods of use for inhibiting bone loss and lowering serum cholesterol |
| 09/02/1995 | CA2143604A1 Fatty acid derivatives |
| 09/02/1995 | CA2143603A1 Fatty acid derivatives |
| 08/31/1995 | WO1995023216A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained |
| 08/31/1995 | WO1995023161A1 Growth arrest homeobox gene |
| 08/31/1995 | WO1995023160A1 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 08/31/1995 | WO1995023157A1 4-n-substituted sialic acids and their sialosides |
| 08/31/1995 | WO1995023156A1 Structure of a novel lipid a and methods utilizing same |
| 08/31/1995 | WO1995023151A1 Pyrrolo(2,3-d)pyrimidine derivatives as antivirals |
| 08/31/1995 | WO1995023150A1 Carbapenem derivative |
| 08/31/1995 | WO1995023149A1 Phenylalkylamino derivatives of condensed carbapenemes |
| 08/31/1995 | WO1995023145A1 New anthraquinonic derivatives having an antitumor activity, and applications thereof |
| 08/31/1995 | WO1995023144A1 Agent acting on the central nervous system, process for its preparation and pharmaceutical compositions containing it |
| 08/31/1995 | WO1995023141A1 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents |
| 08/31/1995 | WO1995023140A1 Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives |
| 08/31/1995 | WO1995023139A1 Optically pure 4-aryl-2-hydroxytetronic acids |
| 08/31/1995 | WO1995023138A1 Pyrimidine acyclonucleoside derivatives |
| 08/31/1995 | WO1995023137A1 Acetic acid amide derivatives and process for the preparation thereof |
| 08/31/1995 | WO1995023134A1 Therapeutic benzonitriles |
| 08/31/1995 | WO1995023133A1 Therapeutic benzonitriles |
| 08/31/1995 | WO1995023132A1 Blockers of ion channels and methods of use thereof |
| 08/31/1995 | WO1995023128A1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity |
| 08/31/1995 | WO1995023127A1 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity |
| 08/31/1995 | WO1995022993A1 Method and device for the provocation of air passage narrowing and/or the induction of sputum |
| 08/31/1995 | WO1995022988A1 Vacuolating toxin-deficient h. pylori and related methods |
| 08/31/1995 | WO1995022983A1 Topical composition for the treatment of aphthous ulcers containing an antimicrobial agent and a corticosteroid |
| 08/31/1995 | WO1995022976A1 Liquid paraffin oil and lactulose-based hypocaloric laxative jelly and method for its preparation |
| 08/31/1995 | WO1995022975A1 Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus |
| 08/31/1995 | WO1995022974A2 Film coated tablet of paracetamol and domperidone |
| 08/31/1995 | WO1995022973A1 Injectable emulsions containing antifungal triazole derivatives |
| 08/31/1995 | WO1995022972A1 Rapamycin derivatives |
| 08/31/1995 | WO1995022971A1 Anti-inflammatory and infection protective effects of sesamin-based lignans |
| 08/31/1995 | WO1995022970A1 Patch containing isosorbide dinitrate and prepared by using adhesive mixture |
| 08/31/1995 | WO1995022969A1 Method of treatment of cancer as well as method of inhibition of lactation in mammals |
| 08/31/1995 | WO1995022968A1 δ-(S-METHYLISOTHIOUREIDO)-L-NORVALINE AND CEREBROVASCULAR DISORDER REMEDY HAVING NITROGEN MONOXIDE SYNTHASE INHIBITOR ACTIVITY |
| 08/31/1995 | WO1995022967A1 Analgesic activity enhancer |
| 08/31/1995 | WO1995022966A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
| 08/31/1995 | WO1995022965A2 Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 08/31/1995 | WO1995022964A1 Transdermal presentation of nitroglycerin for preventing undesired labour |
| 08/31/1995 | WO1995022959A2 Sunscreen compositions |
| 08/31/1995 | WO1995022908A1 Ready-to-eat cereal product fortified with ferric edta |
| 08/31/1995 | WO1995018821A3 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use |
| 08/31/1995 | DE4406915A1 Contraceptive pack for ovulation inhibition |
| 08/31/1995 | DE4406462A1 Prodn. of pharmaceutical as molecular dispersion in solid carrier |
| 08/31/1995 | DE4406073A1 Verfahren zur Herstellung von humanen, klonogenen Fibroblasten, Verfahren zur Gentransfizierung von Fibroblasten und so erhaltene Fibroblasten A process for the production of human, clonogenic fibroblasts method for Gentransfizierung of fibroblasts and fibroblasts thus obtained |
| 08/31/1995 | CA2596947A1 Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 08/31/1995 | CA2468048A1 Process for purifying chemically synthesized rna |
| 08/31/1995 | CA2184389A1 Patch containing isosorbide dinitrate and prepared by using adhesive mixture |
| 08/31/1995 | CA2184283A1 Structure of a novel lipid a and methods utilizing same |
| 08/31/1995 | CA2184201A1 Transdermal presentation of nitroglycerin for preventing undesired labour |
| 08/31/1995 | CA2184199A1 Pyrrolo(2,3-d)pyrimidine derivatives as antivirals |
| 08/31/1995 | CA2184198A1 Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters |
| 08/31/1995 | CA2184155A1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity |
| 08/31/1995 | CA2184093A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
| 08/31/1995 | CA2184068A1 Optically pure 4-aryl-2-hydroxytetronic acids |
| 08/31/1995 | CA2183863A1 Growth arrest homeobox gene |
| 08/31/1995 | CA2183769A1 Vacuolating toxin-deficient h. pylori and related methods |
| 08/31/1995 | CA2183637A1 Anti-inflammatory and infection protective effects of sesamin-based lignans |
| 08/31/1995 | CA2183438A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained |
| 08/31/1995 | CA2183422A1 Analgesic activity enhancer |
| 08/31/1995 | CA2182698A1 Injectable emulsions containing antifungal triazole derivatives |
| 08/31/1995 | CA2181237A1 4-n-substituted sialic acids and their sialosides |
| 08/31/1995 | CA2161318A1 New anthraquinonic derivatives having an antitumor activity, and applications thereof |
| 08/31/1995 | CA2160717A1 A drug active on the central nervous system, a process for the preparation thereof and pharmaceutical compositions containing it |
| 08/30/1995 | EP0669343A1 Cyclic depsipeptides containing lactic acid with 18 ring atoms as endoparasiticidal agents and process for their preparation |
| 08/30/1995 | EP0669341A1 Therapeutic Nucleosides |
| 08/30/1995 | EP0669333A1 New imidazopyridine derivatives as angiotensin II antagonists |
| 08/30/1995 | EP0669331A1 Benzodioxane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/30/1995 | EP0669322A1 Substituted sulfonamides, process for their preparation and pharmaceutical compositions containing them |
| 08/30/1995 | EP0669316A1 Analogs of 15-déoxyspergualine, process for their preparation and their use as immunosuppressive agents |
| 08/30/1995 | EP0669311A1 Benzamides |
| 08/30/1995 | EP0669132A1 Pharmaceutical composition of vitamin E and acetylsalicylate for treatment and prevention of atherosclerosis |
| 08/30/1995 | EP0669131A1 Aquous concentrated solutions containing argatroban |
| 08/30/1995 | EP0669128A1 Sustained-release microsphere containing antipsychotic and process for producing the same |
| 08/30/1995 | EP0669127A1 Prolonged-action pharmaceutical preparation |
| 08/30/1995 | EP0669125A1 Self tanning cosmetic compositions containing dihydroxyacetone |
| 08/30/1995 | EP0668933A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 08/30/1995 | EP0668913A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 08/30/1995 | EP0668874A1 Lhrh antagonists and intermediate products |